These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2369572)

  • 21. Use of cyclosporin in psoriasis.
    Bos JD; Meinardi MM; van Joost T; Heule F; Powles AV; Fry L
    Lancet; 1989 Dec 23-30; 2(8678-8679):1500-2. PubMed ID: 2574777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels.
    Heydendael VM; Spuls PI; Ten Berge IJ; Opmeer BC; Bos JD; de Rie MA
    Br J Dermatol; 2002 Jul; 147(1):122-9. PubMed ID: 12100194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands.
    Meinardi MM; de Rie MA; Bos JD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():27-31. PubMed ID: 2196081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between lymphocyte cyclosporin sensitivity and clinical progress of psoriasis.
    Umezawa Y; Oh-i T; Koga M
    J Dermatol Sci; 2001 Jun; 26(2):94-9. PubMed ID: 11378324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term use of cyclosporin A in severe psoriasis.
    Van Joost T; Heule F; Stolz E; Beukers R
    Br J Dermatol; 1986 May; 114(5):615-20. PubMed ID: 3718852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal side-effects of cyclosporin A with special reference to autoimmune diseases.
    Mihatsch MJ; Thiel G; Ryffel B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():101-15. PubMed ID: 2196077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
    Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect assessment of renal dysfunction in patients taking cyclosporin A for autoimmune diseases.
    Mason J; Moore LC
    Br J Dermatol; 1990 Jun; 122 Suppl 36():79-84. PubMed ID: 2369571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of cyclosporin A in psoriasis: a summary of the United States' experience.
    Fradin MS; Ellis CN; Voorhees JJ
    Br J Dermatol; 1990 Jun; 122 Suppl 36():21-5. PubMed ID: 2196080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.
    Maza A; Montaudié H; Sbidian E; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP; Paul C
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():19-27. PubMed ID: 21388455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of PUVA- and retinoid-PUVA-resistant severe psoriasis with systemic cyclosporin A.
    Takashima A; Morita A; Tsuji T
    J Dermatol; 1990 Aug; 17(8):482-8. PubMed ID: 2229652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
    Yee GC; Kennedy MS; Gmur DJ; Self SG; Deeg HJ
    Bone Marrow Transplant; 1987 Feb; 1(3):289-95. PubMed ID: 3332139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Bjerkhoel F; Amundsen E; Djøseland O; Rugstad HE; Westre B
    Kidney Int; 1986 Jun; 29(6):1180-7. PubMed ID: 3528611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose cyclosporine in rheumatoid arthritis: a pilot study.
    Tugwell P; Bombardier C; Gent M; Bennett K; Ludwin D; Grace E; Buchanan WW; Bensen WG; Bellamy N; Murphy GF
    J Rheumatol; 1987 Dec; 14(6):1108-14. PubMed ID: 3437417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosage of Cyclosporin A in children with renal transplants.
    Hoyer PF; Offner G; Wonigeit K; Brodehl J; Pichlmayr R
    Clin Nephrol; 1984 Aug; 22(2):68-71. PubMed ID: 6383673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of immunosuppression by serum inhibition of alloreaction and measurement of cyclosporin A (CyA) serum levels in kidney graft recipients under CyA.
    Chabannes D; Vernillet L; Cantarovich D; Humbert H; Vie H; Soulillou JP
    Transpl Int; 1990 Dec; 3(4):189-94. PubMed ID: 2076168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimal dose of cyclosporin in living related kidney transplantation].
    Tanabe K; Takahashi K; Sonda K; Yagisawa T; Oba S; Nakazawa H; Goya N; Yamaguchi Y; Fuchinoue S; Nakamura M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):528-35. PubMed ID: 1593833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.